The administration yesterday issued an interim final rule requiring health plans to begin submitting annual information next year on prescription drug coverage and spending, including the most frequently dispensed and costliest drugs, and information on prescription drug rebates and their impact on premiums and out-of-pocket spending. The rule also requires health plans and issuers to report on total spending for health care services by type (e.g., hospital care, primary care, specialty care, prescription drugs and other medical costs, including wellness services); and premium and prescription drug spending by employers versus employees. The departments of Health and Human Services, Labor and Treasury will use the data to issue biennial reports on prescription drug pricing trends and the impact of prescription drug costs on premiums and out-of-pocket costs starting in 2023. 

Related News Articles

Headline
President Biden Feb. 28 directed the Department of Justice to issue regulations to protect personal health and other data from countries known to collect and…
Headline
The Federal Trade Commission and Department of Health and Human Services Feb. 14 requested comments for 60 days on market concentration and contracting…
Headline
Seventeen state hospital associations and 30 hospitals and health systems Jan. 12 filed friend-of-the-court briefs supporting the AHA in its lawsuit…
Headline
An overarching approach to the coming year can be summed up as “letting the data speak and guide us,” writes Joy Lewis, AHA’s senior vice president for health…
Headline
In a letter to the Centers for Medicare & Medicaid Services and Office of the National Coordinator for Health Information Technology, AHA Jan. 2 expressed…
Headline
The Department of Health and Human Services, Department of Justice, and Federal Trade Commission Dec. 7 announced several new actions to promote…